Provided by Tiger Trade Technology Pte. Ltd.

Abbott Laboratories

98.83
-2.1200-2.10%
Post-market: 98.850.0200+0.02%19:59 EDT
Volume:7.57M
Turnover:750.93M
Market Cap:171.85B
PE:31.98
High:100.63
Open:100.57
Low:98.72
Close:100.95
52wk High:135.45
52wk Low:81.97
Shares:1.74B
Float Shares:1.70B
Volume Ratio:0.92
T/O Rate:0.44%
Dividend:2.48
Dividend Rate:2.51%
EPS(TTM):3.09
EPS(LYR):3.73
ROE:10.58%
ROA:5.33%
PB:3.36
PE(LYR):26.50

Loading ...

Abbott Reaches Agreement with Department of Justice to Resolve Claims Relating to 2022 Infant Formula Recall

THOMSON REUTERS
·
Sep 14

Abbott - to Pay $385 Mln to Resolve Claims; no Finding of Fault or Liability

THOMSON REUTERS
·
Sep 14

U.S. Justice Department Says Abbott Agrees to Pay over $384M to Settle Allegations Related to Contaminated Infant Formula

THOMSON REUTERS
·
Sep 14

Abbott to pay over $384M to settle infant formula allegations

TIPRANKS
·
Sep 14

Agilent Technologies Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 12

Edwards Lifesciences Corp. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Sep 12

Texas Gov. Abbott, Seeking Re-Election, Touts Border Security, Voter ID Law

Dow Jones
·
Sep 11

Perrigo Co. PLC Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
Sep 11

Abbott Laboratories Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
Sep 11

Analysts Offer Insights on Healthcare Companies: Abbott Laboratories (ABT), Pharvaris (PHVS) and Zimmer Biomet Holdings (ZBH)

TIPRANKS
·
Sep 09

Edwards Lifesciences Corp. Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Sep 09

Medtronic PLC Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Sep 09

Abbott Laboratories Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Sep 09

Abbott Labs Price Target Maintained with a $135.00/Share by TD Cowen

Dow Jones
·
Sep 08

Abbott Wins FDA Approval for TactiFlex Duo Dual-Energy AFib Ablation Catheter

Reuters
·
Sep 08

Abbott Receives FDA Approval for Its Tactiflex™ Duo Ablation Catheter to Treat People with Abnormal Heart Rhythms

THOMSON REUTERS
·
Sep 08

Abbott - to Begin Broader Commercial Adoption of Tactiflex Duo in U.S. in Coming Weeks

THOMSON REUTERS
·
Sep 08

Asep Medical Restructures Stakes in ABT and Sepset While Preserving Economic Upside

TIPRANKS
·
Sep 06

BOB Capital Markets Cuts Abbott India PT on Slower Sales Growth Outlook

Reuters
·
Sep 04

Abbott VP, Controller John A. McCoy Jr Disposes of Common Shares Worth $8,685.45

Reuters
·
Sep 04